CML is characterized by the presence of a constitutively active tyrosine kinase, known as the BCR/ABL oncoprotein, which is produced as a result of a reciprocal translocation between chromosomes 9 and 22 (1). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.